• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Monkeypox (MPX) Reporting Protocol Version 3.1, 8 September 2022 - ECDC

Mary Wilson

Well-known member
Introduction
This reporting protocol is intended for reporting national case-based data for surveillance of monkeypox from all the countries and areas of the WHO European Region, including the 27 countries of the European Union (EU) and the additional three countries of the European Economic Area (EEA), to the European level.

Data are submitted through the case-based record type MPX to the European Surveillance System (TESSy) database hosted at ECDC.

Data can be reported to TESSy either manually, for entry of single cases, or through metadata- standardised CSV or XML files for multiple cases (please see technical annex).

Case data including retrospective updates to cases already in TESSy should be reported
weekly, Tuesdays by 10:00AM.

This reporting protocol is supplemented by a technical annex, which contains updated generic information for data submission.
First cases should be reported to WHO/ECDC through IHR/EWRS mechanisms. Any additional cases should be reported to TESSy only. Please note that all data are collected jointly with the World Health Organisation – Regional Office for Europe (WHO/Europe) to fulfil Member States reporting requirements to WHO. Duplicate reporting is therefore not required.

Case definition
Probable and confirmed cases should be reported according to the current WHO case definition for monkeypox (Annex 2). Information on the case definition used should be provided in the variable CaseDefinition. If a national case definition is used this information should also be provided in the variable CaseDefinition.

Aim
To support the timely and complete reporting of key information on monkeypox epidemiology in the countries and areas of the WHO European Region, including the 27 countries of the European Union (EU) and the additional three countries of the European Economic Area (EEA).

Surveillance Objectives
  1. Monitor the intensity and geographical spread of the monkeypox virus in the population in time, place and person;
  2. To understand the natural history and epidemiology of the disease including risk factors for infection in order to assess its impact and prepare accordingly
  3. To describe the population at highest risk of infection and severe outcomes in order to target preventive or control measures
  4. Assess the impact of any control and prevention measures.
https://www.ecdc.europa.eu/sites/default/files/documents/MPX_Reporting-Protocol_v3.1.pdf
 
Back
Top